Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Uyen Minh Le, Amanda Hartman & Gopalakrishna Pillai. (2018) Enhanced selective cellular uptake and cytotoxicity of epidermal growth factor-conjugated liposomes containing curcumin on EGFR-overexpressed pancreatic cancer cells. Journal of Drug Targeting 26:8, pages 676-683.
Read now
Read now
Articles from other publishers (28)
Mangala Hegde, Sosmitha Girisa, Nikunj Naliyadhara, Aviral Kumar, Mohammed S. Alqahtani, Mohamed Abbas, Chakrabhavi Dhananjaya Mohan, Sudha Warrier, Kam Man Hui, Kanchugarakoppal S. Rangappa, Gautam Sethi & Ajaikumar B. Kunnumakkara. (2022) Natural compounds targeting nuclear receptors for effective cancer therapy. Cancer and Metastasis Reviews 42:3, pages 765-822.
Crossref
Crossref
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda & Mithun Chakraborty. (2022) Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19. European Journal of Medicinal Chemistry Reports 6, pages 100079.
Crossref
Crossref
Nurul Azwa Abd. Wahab, Faridah Abas, Iekhsan Othman & Rakesh Naidu. (2021) Diarylpentanoid (1,5-bis(4-hydroxy-3-methoxyphenyl)-1,4-pentadiene-3-one) (MS13) Exhibits Anti-proliferative, Apoptosis Induction and Anti-migration Properties on Androgen-independent Human Prostate Cancer by Targeting Cell Cycle–Apoptosis and PI3K Signalling Pathways. Frontiers in Pharmacology 12.
Crossref
Crossref
Bruna A. C. Rattis, Simone G. Ramos & Mara R. N. Celes. (2021) Curcumin as a Potential Treatment for COVID-19. Frontiers in Pharmacology 12.
Crossref
Crossref
A. Harikrishnan, Sunali Khanna & V. Veena. (2021) Design of New Improved Curcumin Derivatives to Multi-targets of Cancer and Inflammation. Current Drug Targets 22:5, pages 573-589.
Crossref
Crossref
Shashwat Sharad, Travis C. Allemang, Hua Li, Darryl Nousome, Anson Tai Ku, Nichelle C. Whitlock, Adam G. Sowalsky, Jennifer Cullen, Isabell A. Sesterhenn, David G. McLeod, Shiv Srivastava & Albert Dobi. (2021) Age and Tumor Differentiation-Associated Gene Expression Based Analysis of Non-Familial Prostate Cancers. Frontiers in Oncology 10.
Crossref
Crossref
Marco Bisoffi & Justin M. O’Neill. 2021. Cancer. Cancer
371
386
.
Deborah Termini, Danja J. Den Hartogh, Alina Jaglanian & Evangelia Tsiani. (2020) Curcumin against Prostate Cancer: Current Evidence. Biomolecules 10:11, pages 1536.
Crossref
Crossref
Nurul Azwa Abd. Wahab, Nordin H. Lajis, Faridah Abas, Iekhsan Othman & Rakesh Naidu. (2020) Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer. Nutrients 12:3, pages 679.
Crossref
Crossref
A. Golonko, H. Lewandowska, R. Świsłocka, U.T. Jasińska, W. Priebe & W. Lewandowski. (2019) Curcumin as tyrosine kinase inhibitor in cancer treatment. European Journal of Medicinal Chemistry 181, pages 111512.
Crossref
Crossref
Shilpa Katta, Arun Srivastava, Rajesh L. Thangapazham, Inger L. Rosner, Jennifer Cullen, Hua Li & Shashwat Sharad. (2019) Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells. International Journal of Molecular Sciences 20:19, pages 4891.
Crossref
Crossref
Chiara Costa, Aristidis Tsatsakis, Charalampos Mamoulakis, Michele Teodoro, Giusi Briguglio, Emanuela Caruso, Dimitris Tsoukalas, Denisa Margina, Efthimios Dardiotis, Demetrios Kouretas & Concettina Fenga. (2017) Current evidence on the effect of dietary polyphenols intake on chronic diseases. Food and Chemical Toxicology 110, pages 286-299.
Crossref
Crossref
J L Wright, L Chéry, S Holt, D W Lin, M Luedeke, A E Rinckleb, C Maier & J L Stanford. (2015) Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status. Prostate Cancer and Prostatic Diseases 19:1, pages 53-56.
Crossref
Crossref
Jing Li, SongTao Xiang, QiouHong Zhang, JingJing Wu, Qing Tang, JianFu Zhou, LiJun Yang, ZhiQiang Chen & Swei Sunny Hann. (2015) Combination of curcumin and bicalutamide enhanced the growth inhibition of androgen-independent prostate cancer cells through SAPK/JNK and MEK/ERK1/2-mediated targeting NF-κB/p65 and MUC1-C. Journal of Experimental & Clinical Cancer Research 34:1.
Crossref
Crossref
Shigeo Horie. 2015. Nutraceuticals and Functional Foods in Human Health and Disease Prevention. Nutraceuticals and Functional Foods in Human Health and Disease Prevention
421
442
.
Massimo Fantini, Monica Benvenuto, Laura Masuelli, Giovanni Frajese, Ilaria Tresoldi, Andrea Modesti & Roberto Bei. (2015) In Vitro and in Vivo Antitumoral Effects of Combinations of Polyphenols, or Polyphenols and Anticancer Drugs: Perspectives on Cancer Treatment. International Journal of Molecular Sciences 16:12, pages 9236-9282.
Crossref
Crossref
Michal Heger, Rowan F. van Golen, Mans Broekgaarden & Martin C. Michel. (2013) The Molecular Basis for the Pharmacokinetics and Pharmacodynamics of Curcumin and Its Metabolites in Relation to Cancer. Pharmacological Reviews 66:1, pages 222-307.
Crossref
Crossref
Alexandra M. Fajardo & Marco Bisoffi. 2014. Cancer. Cancer
191
202
.
Takaaki Harada, Lauren Giorgio, Tiffany J. Harris, Duc-Truc Pham, Huy Tien Ngo, Eleanor F. Need, Brendon J. Coventry, Stephen F. Lincoln, Christopher J. Easton, Grant Buchanan & Tak W. Kee. (2013) Diamide Linked γ-Cyclodextrin Dimers as Molecular-Scale Delivery Systems for the Medicinal Pigment Curcumin to Prostate Cancer Cells. Molecular Pharmaceutics 10:12, pages 4481-4490.
Crossref
Crossref
Vanna Sanna, Imtiaz A. Siddiqui, Mario Sechi & Hasan Mukhtar. (2013) Nanoformulation of natural products for prevention and therapy of prostate cancer. Cancer Letters 334:1, pages 142-151.
Crossref
Crossref
Misaki Ono, Takako Higuchi, Mikako Takeshima, Chen Chen & Shuji Nakano. (2013) Differential anti-tumor activities of curcumin against Ras- and Src-activated human adenocarcinoma cells. Biochemical and Biophysical Research Communications 436:2, pages 186-191.
Crossref
Crossref
Samuel J. Klempner & Glenn Bubley. (2012) Complementary and Alternative Medicines in Prostate Cancer: From Bench to Bedside?. The Oncologist 17:6, pages 830-837.
Crossref
Crossref
Shigeo Horie. (2012) Chemoprevention of Prostate Cancer: Soy Isoflavones and Curcumin. Korean Journal of Urology 53:10, pages 665.
Crossref
Crossref
Murielle Mimeault & Surinder K Batra. (2011) Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy. Chinese Medicine 6:1, pages 31.
Crossref
Crossref
Ebtesam A. Al-Suhaimi, Noorah A. Al-Riziza & Reham A. Al-Essa. (2012) Physiological and Therapeutical Roles of Ginger and Turmeric on Endocrine Functions. The American Journal of Chinese Medicine 39:02, pages 215-231.
Crossref
Crossref
Siqing Fu & Razelle Kurzrock. (2010) Development of curcumin as an epigenetic agent. Cancer 116:20, pages 4670-4676.
Crossref
Crossref
Marie-Hélène Teiten, François Gaascht, Serge Eifes, Mario Dicato & Marc Diederich. (2009) Chemopreventive potential of curcumin in prostate cancer. Genes & Nutrition 5:1, pages 61-74.
Crossref
Crossref
Marie-Hélène Teiten, Serge Eifes, Mario Dicato & Marc Diederich. (2010) Curcumin―The Paradigm of a Multi-Target Natural Compound with Applications in Cancer Prevention and Treatment. Toxins 2:1, pages 128-162.
Crossref
Crossref